Literature DB >> 2274283

Reduction of local cerebral blood flow to pathological levels by endothelin-1 applied to the middle cerebral artery in the rat.

M J Robinson1, I M Macrae, M Todd, J L Reid, J McCulloch.   

Abstract

Endothelin-1 (1 nmol) was applied to the exposed left middle cerebral artery (MCA) in anaesthetised adult male Sprague-Dawley rats. Local cerebral blood flow (1CBF), using [14C]iodoantipyrine and quantitative autoradiography, was measured in 27 anatomically defined structures, 10 min after topical application of endothelin-1. In those areas supplied by the MCA, 1CBF was markedly reduced beyond the threshold for ischaemic damage (e.g. dorsolateral caudate nucleus reduced from 131 +/- 3 to 29 +/- 25 ml.100 g-1.min-1, sensorimotor cortex from 109 +/- 5 to 31 +/- 21 ml.100 g-1.min-1). Distant areas were not affected.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2274283     DOI: 10.1016/0304-3940(90)90644-o

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  25 in total

Review 1.  Vascular plasticity in cerebrovascular disorders.

Authors:  Lars I H Edvinsson; Gro Klitgaard Povlsen
Journal:  J Cereb Blood Flow Metab       Date:  2011-05-11       Impact factor: 6.200

2.  Endothelin-1 induced middle cerebral artery occlusion model for ischemic stroke with laser Doppler flowmetry guidance in rat.

Authors:  Saeed Ansari; Hassan Azari; Kenneth J Caldwell; Robert W Regenhardt; Vishnumurthy S Hedna; Micheal F Waters; Brian L Hoh; Adam P Mecca
Journal:  J Vis Exp       Date:  2013-02-16       Impact factor: 1.355

3.  Sensitivity of diffusion MRI to perilesional reactive astrogliosis in focal ischemia.

Authors:  Rachel A Weber; Clifford H Chan; Xingju Nie; Emily Maggioncalda; Grace Valiulis; Abigail Lauer; Edward S Hui; Jens H Jensen; DeAnna L Adkins
Journal:  NMR Biomed       Date:  2017-03-08       Impact factor: 4.044

Review 4.  Experimental animal models and inflammatory cellular changes in cerebral ischemic and hemorrhagic stroke.

Authors:  Tao Yan; Michael Chopp; Jieli Chen
Journal:  Neurosci Bull       Date:  2015-12-02       Impact factor: 5.203

Review 5.  Stem cell transplantation therapy for multifaceted therapeutic benefits after stroke.

Authors:  Ling Wei; Zheng Z Wei; Michael Qize Jiang; Osama Mohamad; Shan Ping Yu
Journal:  Prog Neurobiol       Date:  2017-03-18       Impact factor: 11.685

6.  Control of cerebral ischemia with magnetic nanoparticles.

Authors:  Jie-Min Jia; Praveen D Chowdary; Xiaofei Gao; Bo Ci; Wenjun Li; Aditi Mulgaonkar; Erik J Plautz; Gedaa Hassan; Amit Kumar; Ann M Stowe; Shao-Hua Yang; Wei Zhou; Xiankai Sun; Bianxiao Cui; Woo-Ping Ge
Journal:  Nat Methods       Date:  2016-12-12       Impact factor: 28.547

7.  Endothelin and aneurysmal subarachnoid haemorrhage: a study of subarachnoid cisternal cerebrospinal fluid.

Authors:  P Gaetani; R Rodriguez y Baena; G Grignani; G Spanu; L Pacchiarini; P Paoletti
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-01       Impact factor: 10.154

8.  Rodent models of focal cerebral ischemia: procedural pitfalls and translational problems.

Authors:  Stefan Braeuninger; Christoph Kleinschnitz
Journal:  Exp Transl Stroke Med       Date:  2009-11-25

Review 9.  New models of focal cerebral ischaemia.

Authors:  I Mhairi Macrae
Journal:  Br J Clin Pharmacol       Date:  1992-10       Impact factor: 4.335

10.  A novel approach to induction and rehabilitation of deficits in forelimb function in a rat model of ischemic stroke.

Authors:  Jessica Mary Livingston-Thomas; Andrew Wilson Hume; Tracy Ann Doucette; Richard Andrew Tasker
Journal:  Acta Pharmacol Sin       Date:  2012-10-29       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.